Aveanna Healthcare (AVAH) Set to Post Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) is anticipated to announce its Q3 2026 results before the market opens on Thursday, November 12th. Analysts expect the company to announce earnings of $0.2072 per share and revenue of $679.48 million for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 12, 2026 at 10:00 AM ET.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. On average, analysts expect Aveanna Healthcare to post $0.77 EPS for the current fiscal year and $0.87 EPS for the next fiscal year.

Aveanna Healthcare Trading Down 0.4%

Shares of AVAH stock opened at $13.20 on Tuesday. Aveanna Healthcare has a 12-month low of $5.93 and a 12-month high of $14.71. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The firm’s 50 day moving average is $13.10 and its 200 day moving average is $9.38. The stock has a market capitalization of $2.88 billion, a P/E ratio of 10.73, a P/E/G ratio of 0.87 and a beta of 2.03.

Insiders Place Their Bets

In other news, CEO Jeff Shaner sold 90,000 shares of Aveanna Healthcare stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $1,035,000.00. Following the transaction, the chief executive officer owned 2,561,972 shares in the company, valued at $29,462,678. This trade represents a 3.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Paul R. Vigano sold 14,500,002 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 48,566,081 shares of company stock valued at $558,509,932. 5.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

AVAH has been the subject of a number of research reports. JPMorgan Chase & Co. boosted their target price on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a research note on Monday, September 14th. Barclays raised their price target on Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a research note on Friday, August 28th. Weiss Ratings raised Aveanna Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, October 14th. Raymond James Financial lifted their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a report on Friday, August 14th. Finally, UBS Group upped their price objective on Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.25.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities.

The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.

Aveanna was formed in 2017 through the combination of several healthcare businesses, including Epic Health Services and PSA Healthcare.